stay up to date on this topic
if you’ve commuted in the gta or montreal, chances are you’ve shared the road with someone who works at abbvie canada. with over 1,000 employees in canada, including montreal and markham, abbvie canada is one of the largest biopharmaceutical companies in the country.
for those people stepping into an abbvie office, that familiar start to the day is, more often than not, inspiring. there’s the professional satisfaction of launching numerous impactful medicines since the company’s establishment in 2013. but what makes abbvie stand out — to both its people and canadian communities — is the commitment to making a difference outside of developing innovative therapies.
you could be forgiven for skepticism when a large, successful company makes such a claim. though in the case of abbvie canada, the track record speaks for itself.
natacha raphael is head of corporate affairs and patient engagement with abbvie canada, whose portfolio includes corporate responsibility and relationships with patient organizations. she’s seen first-hand the meaningful impacts abbvie canada has made to the lives of many across the country.
“in the 12 years since its inception, abbvie canada has launched 44 new medicines in immunology, specifically in dermatology, gastroenterology and rheumatology,” she says. “we’re also in the neuroscience, oncology and vision care spaces and have most recently launched in the ovarian cancer space. our therapies treat over 1 million canadians living with chronic conditions.”
what makes the abbvie approach different is a method they call anchor zero. “rather than just diving into business strategies,” natacha explains, “we actually take a step back and look at the realities of patients and caregivers and what their unmet needs are.”
natacha raphael, head of corporate affairs and patient engagement with abbvie canada. supplied
rather than focusing solely on medicines, anchor zero asks what solutions can holistically make a difference. that’s the driving force behind abbvie providing more than $10 million in funding to canadian health care, patient-focused initiatives, and community organizations.